High-performance liquid chromatographic determination of clioquinol and its conjugates in biological materials

A method has been established for the determination of clioquinol (C) and its glucuronide (CG) and sulfate (CS) in biological materials. C and its internal standard were extracted with benzene-pyridine from samples. CG and CS were also hydrolyzed to C and extracted by the same method. The extracts were evaporated to dryness and redissolved in methanol. The methanol solution was subjected to HPLC using a column packed with Iatrobeads 6cp.2010 and a UV monitor (254 nm). The mobile phase was 0.1 M citric acid-methanol-n-hexane (8:86:6). The detection limit of C and 1 nmole and its recovery was above 92%.     

High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluids.

A high-performance liquid chromatographic method is described for the determination of a fluoroquinolone, rufloxacin, and its N-desmethyl metabolite in plasma, urine and bile. Samples are chromatographed on a poly(styrene-divinylbenzene) column, the eluate being monitored with a fluorescence detector. The method was validated and a detection limit of 10 ng/ml for both rufloxacin and its metabolite in all the biological matrices considered was found. The method was successfully applied in pharmacokinetic studies.     

High-performance liquid chromatographic determination of N-n-propylnorapomorphine and its glucuronide metabolite in blood plasma

Summary Rapid HPLC methods are described for the determinations of either free N-n-propylnorapomorphine (NPA) or the free and conjugated NPA in blood plasma. The methods employ a methanol protein-precipitation step that produces relatively good absolute recoveries, while permitting a simple work-up procedure without derivatization. Only 0.25 ml of plasma is required for a single determination at a sensitivity limit of 0.4g NPA/ml plasma. Satisfactory accuracy and precision are achieved with the proposed assay.

---

Bestimmung von N-n-Propylnorapomorphin (NPA) und dessen Glucuronid in Blutplasma durch Hochleistungs-Flüssigchromatographie

Zusammenfassung Rasche Methoden zur Bestimmung von freiem NPA oder freiem und gebundenem NPA in Blutplasma wurden beschrieben. Nach Eiweißfällung mittels Methanol erhält man relativ gute Absolutwerte nach einfacher Aufarbeitung ohne Derivatisierung. Für eine Einzelbestimmung werden nur 0,25 ml Plasma benötigt. Die Erfassungsgrenze liegt bei 0,4g NPA/ml Plasma. Das Verfahren ist hinreichend genau.

     

High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids

Sensitive and selective high-performance liquid chromatographic assays for diclofenac and its monohydroxylated metabolites in biological fluids are described. Using ultraviolet detection at 282 nm, diclofenac is assayed in plasma at concentrations down to 10 ng/ml; total (free + conjugated) diclofenac and its monohydroxylated metabolites (the sum of 3'- + 4'-hydroxydiclofenac and 5-hydroxydiclofenac) are assayed in urine after chemical hydrolysis at concentrations down to 200 ng/ml. The applicability of the described assays is shown.     

High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids

An isocratic high-performance liquid chromatographic method to determine racemic ibuprofen (assay I) and its major metabolites (assay II) in biological fluids (plasma, urine, bile) using a conventional reversed-phase column is described. A third assay using beta-cyclodextrin as stationary phase (Cyclobond I) for the separation of the ibuprofen enantiomers is also described. A wavelength of 220 nm was used to monitor the substances. The sensitivity of the method was 0.1 microgram/ml for all three assays. The method was demonstrated to be suitable for stereoselective pharmacokinetic studies of ibuprofen in humans and animals.     

High-performance liquid chromatographic determination of proquazone and its m-hydroxy metabolite in spiked human plasma and urine

A simple and rapid high-performance liquid chromatographic method for the determination of proquazone (PQZ) and its major metabolite, m-hydroxyproquazone, in spiked human plasma and urine was developed. Plasma samples were purified using acetonitrile as a protein precipitant, while urine samples were diluted only with the mobile phase and filtered prior to injection. Samples containing the parent compounds and glafenine (internal standard) were eluted from a reversed-phase C8 column using acetonitrile-0.025 M sodium acetate (60 + 40) adjusted to pH 5 as the mobile phase and detected at 234 nm. Peak area ratios of the analytes versus internal standard were used for calibration. The mean recoveries from plasma and urine samples spiked with PQZ and its m-hydroxy metabolite ranged from 97.87 to 103.88%. The relative standard deviation for the within- and between-day analyses were < 4%. The proposed method was applied for the assay of PQZ in laboratory-made tablets.     

High-performance liquid chromatographic determination of FCE 24928, a new aromatase inhibitor, in human plasma

A sensitive and selective high-performance liquid chromatographic method for the determination of FCE 24928 (4-amino-androsta-1,4,6-triene-3, 17-dione) in human plasma is reported. The drug was extracted from buffered (pH = 8) plasma samples with methylene chloride-isooctane, then analysed by reversed-phase liquid chromatography. Quantitation was achieved by ultraviolet detection of the eluate at 238 nm. Blank plasma samples from humans, dog and rat assayed as described showed no significant peak at the retention time of the compound of interest. The suitability of the method for in vivo samples was tested by measuring the plasma levels of FCE 24928 in rats that received oral doses of the test compound.     

High-performance liquid chromatographic methods for the determination of ranitidine and its metabolites in biological fluids

Summary The use of an existing reversed-phase ion-pair method for the determination of ranitidine, ranitidine-N-oxide, ranitidine-S-oxide and desmethylranitidine in the plasma of patients taking the anti-ulcer drug, ranitidine is described. The development of a ternary reversed-phase system which is more suitable for the routine determination of ranitidine and the three metabolites is reported. This system has been used to determine quantitatively ranitidine and the metabolites in urine. Studies in animals using¹⁴C-ranitidine have shown that ranitidine is also oxidatively deaminated to a 5-substituted, 2-furan carboxylic acid. A reversed-phase ion-pair system, in which cetrimide is the counter ion, has been developed for the quantitative determination of the 5-substituted, 2-furan carboxylic acid and ranitidine-N-oxide in urine and faeces from patients treated with ranitidine. Presented at the 15th International Symposium on Chromatography, Nürnberg, October 1984